Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 1997

View Archived Issues

Immune Response's TCR vaccine evaluated in MS patients

Parke-Davis initiates QUASAR trial of quinapril

Dovetail issued patent for Betathine

Pacific Pharmaceuticals and Steri-Oss sign distribution agreement

Familial Mediterranean fever gene discovered

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

BMS reports new cephalosporins active against MRSA

Tasmar approved in EU for Parkinson's disease

Gensia's injectable diltiazem receives ANDA approval

Roche withdraws NDA for orlistat

FDA approves Hi-Tech's generic promethazine/codeine syrup

Marketing agreement reached for Abelcet in France and Italy

Eurand and Global enter pancrelipase agreement

Canadian marketing clearance granted for Emdogain

Morphine derivatives discovered by Nycomed

FDA approves nonsurgical treatment for BPH

ImmunoGen's apoptosis research receives patent protection

Alza will acquire Therapeutic Discovery Corporation

Val-HeFT will evaluate valsartan in CHF

New Parkinson's disease treatment option now available in Canada

New indication approved for Asacol

First regulatory submission filed for Macritonin

CURVES study results point in favor of atorvastatin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...